Thrombosis pp 123-133 | Cite as

Animal Models: Importance in Research on Hemorrhage and Thrombosis

  • K. M. Brinkhous
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 102)


Despite some sentiments against animal research, animal models continue to be important in studying hemorrhage and thrombosis. Examples of genetic models are dogs and pigs with von Willebrand’s disease. The homozygous von Willebrand pig appears to be resistant to arteriosclerosis, presumably due to impairment of the platelet aggregating function. Among acquired models, pigs are gaining in favor, perhaps because their clotting and platelet characteristics resemble those in humans. Species vary markedly in their normal plasma levels of platelet aggregating factor/von Willebrand factor (PAF/vWF). One promising approach to the study of thrombosis is using platelet anti-aggregating drugs to inhibit PAF/vWF dependent platelet thrombus formation; a drug-induced von Willebrand state seems feasible.


Hemorrhagic Disease Normal Plasma Level Pulmonary Thrombosis Impaired Animal Platelet Aggregate Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    ANIMAL MODELS OF THROMBOSIS AND HEMORRHAGIC DISEASES. Cosponsored by the National Heart and Lung Institute and the Institute of Laboratory Animal Resources, National Academy of Sciences. Washington, DC, National Institutes of Health, 1975.Google Scholar
  2. 2.
    THE FUTURE OF ANIMALS, CELLS, MODELS, AND SYSTEMS IN RESEARCH, DEVELOPMENT, EDUCATION, AND TESTING. Proceedings of a Symposium, Institute of Laboratory Animal Resources, Division of Biological Sciences, Assembly of Life Sciences. Washington, DC, National Academy of Sciences, 1977.Google Scholar
  3. 3.
    Saba SR, Mason RG: Studies of an activity from endothelial cells that inhibits platelet aggregation, serotonin release and clot retraction. THROMB RES 5: 747–757, 1974.PubMedCrossRefGoogle Scholar
  4. 4.
    Johnson RA, Morton DR, Kinner JH, Gorman RR, McGuire JC, Sun FF: The chemical structure of prostaglandin X (prostacyclin). PROSTAGLANDINS 12: 915–928, 1976.PubMedGoogle Scholar
  5. 5.
    McDonald RI, Shepro D, Rosenthal M, Booyse FM: Properties of cultured endothelial cells. SER HAEMATOL VI, 4: 469–478, 1973.Google Scholar
  6. 6.
    Zeldis SM, Nemerson Y, Pitlick FA, Lentz TL: Tissue factor (thromboplastin): Localization to plasma membranes by peroxidase-conjugated antibodies. SCIENCE 175: 766–768, 1972.PubMedCrossRefGoogle Scholar
  7. 7.
    Jaffe EA, Hoyer LW, Nachman RL: Synthesis of von Willebrand factor by cultured human endothelial cells. PROC NATL ACAD SCI USA 71: 1906–1909, 1974.PubMedCrossRefGoogle Scholar
  8. 8.
    Bloom AL, Peake IR, Giddings JC, Shearn SAM, Tuddenham EGD: Endothelial cells and factor-VIII-related protein. LANCET 1: 46, 1976.PubMedCrossRefGoogle Scholar
  9. 9.
    Nopanitaya W, Gambill TG, Brinkhous KM: Fresh water drowning. Pulmonary ultrastructure and systemic fibrinolysis. ARCH PATHOL 98: 361–366, 1974.PubMedGoogle Scholar
  10. 10.
    Seager SWJ: Cost-effectiveness: Utilization of a sperm bank in animal breeding colonies. In ANIMAL MODELS OF THROMBOSIS AND HEMORRHAGIC DISEASE. Co-sponsored by the National Heart and Lung Institute and the Institute of Laboratory Animal Resources, National Academy of Sciences. Washington, DC, National Institutes of Health, 1975, p. 118.Google Scholar
  11. 11.
    Henry RL: Methods for inducing experimental thrombosis. ANGIOLOGY 13: 554–577, 1962.PubMedCrossRefGoogle Scholar
  12. 12.
    Didisheim P: Animal models useful in the study of thrombosis and antithrombotic agents. PROG HEMOST THROMB 1: 165–197, 1972.PubMedGoogle Scholar
  13. 13.
    Dodds WJ: Hereditary and acquired hemorrhagic disorders in animals. PROG HEMOST THROMB 2: 215–247, 1974.PubMedGoogle Scholar
  14. 14.
    Tomikawa M, Ogawa H, Abiko Y: Experimental model of pulmonary thrombosis in rat. THROMB DIATH HAEMORRH 31: 86–102, 1974.PubMedGoogle Scholar
  15. 15.
    Strachan CJL, Gaffney PJ, Scully MF, Kakkar VV: An experimental model for the study of venous thrombis in vivo. THROMB RES 5: 235–242, 1974.PubMedCrossRefGoogle Scholar
  16. 16.
    Chan PS, Ellenbogen L: Laser-induced injury in mouse ear arteries as a model for in vivo studies of arterial thrombosis. THROMB RES 5: 529–537, 1974.CrossRefGoogle Scholar
  17. 17.
    Brinkhous KM, Davis PD, Graham JB, Dodds WJ: Expression and linkage of genes for X-linked hemophilias A and B in the dog. BLOOD 41: 577–585, 1973.PubMedGoogle Scholar
  18. 18.
    Graham JB, Buckwalter JA, Hartley LJ, Brinkhous KM: Canine hemophilia. Observations of the course, the clotting anomaly, and the effect of blood transfusions. J EXP MED 90: 97–111, 1949.PubMedCrossRefGoogle Scholar
  19. 19.
    Parks BJ, Brinkhous KM, Harris PF, Penick GD: Laboratory detection of female carriers of canine hemophilia. THROMB DIATH HAEMORRH 12: 368–376, 1964.PubMedGoogle Scholar
  20. 20.
    Mustard JF, Rowsell HC, Robinson GA, Hoeksema TD, Downie HG: Canine hemophilia B (Christmas disease). BR J HAEMATOL 6: 259–266, 1960.PubMedCrossRefGoogle Scholar
  21. 21.
    Brinkhous KM, Graham JB: Hemophilia in the female dog. SCIENCE 111: 723–724, 1950.PubMedCrossRefGoogle Scholar
  22. 22.
    Fuster V, Bowie EJW, Josa M, Kaye MP: Atherosclerosis in normal and von Willebrand pigs receiving a high cholesterol diet: Control and cross-aortic transplantation studies. CIRCULATION (Suppl) (In Press).Google Scholar
  23. 23.
    Bustad LK, McClellan RO, Burns MP (editors): SWINE IN BIOMEDICAL RESEARCH. Richland, Wash., Battelle-Northwest, 1966.Google Scholar
  24. 24.
    Hawkey CM: The relationship between blood coagulation and thrombosis and atherosclerosis in man, monkeys and carnivores. THROMB DIATH HAEMORRH 31: 103–118, 1974.PubMedGoogle Scholar
  25. 25.
    Lewis JH: Comparative hematology: Studies on Chiroptera, Pteropus giganteous. COMP BIOCHEM PHYSIOL 58A: 103–107, 1977.CrossRefGoogle Scholar
  26. 26.
    Lewis JH, Phillips LL, Hann C: Coagulation and hematological studies in primative Australian mammals COMP BIOCHEM PHYSIOL 25: 1129–1135, 1968.Google Scholar
  27. 27.
    Mason RG, Read MS: Platelet response to six agglutinating agents: Species similarities and differences. EXP MOL PATHOL 6: 370–381, 1967.PubMedCrossRefGoogle Scholar
  28. 28.
    Mason RG, Read MS: Some species differences in fibrinolysis and blood coagulation. J BIOMED MATER RES 5: 121–128, 1971.PubMedCrossRefGoogle Scholar
  29. 29.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J: Quantitative assay of a plasma factor deficient in von Willebrand’s disease that is necessary for platelet aggregation. J CLIN INVEST 52: 2708–2716, 1973.PubMedCrossRefGoogle Scholar
  30. 30.
    Sarji KE, Stratton RD, Wagner RH, Brinkhous KM: Nature of von Willebrand factor: A new assay and a specific inhibitor. PROC NATL ACAD SCI USA 71: 2937–2941, 1974.PubMedCrossRefGoogle Scholar
  31. 31.
    Allain JP, Cooper HA, Wagner RH, Brinkhous KM: Platelets fixed with paraformaldehyde: A new reagent for assay of von Willebrand factor and platelet aggregating factor. J LAB CLIN MED 85: 318–328, 1975.PubMedGoogle Scholar
  32. 32.
    Brinkhous KM, Graham JE, Cooper HA, Allain JP, Wagner RH: Assay of von Willebrand factor in von Willebrand’s disease and hemophilia: Use of a macroscopic platelet aggregation test. THROMB RES 6: 267–272, 1975.PubMedCrossRefGoogle Scholar
  33. 33.
    Brinkhous KM, Thomas BD, Ibrahim SA, Read MS: Plasma levels of platelet aggregating factor/von Willebrand factor in various species. THROMB RES 11: 345–355, 1977.PubMedCrossRefGoogle Scholar
  34. 34.
    Geratz JD, Tidwell RR, Brinkhous KM, Mohammed SF, Dann 0, Loewe H: Specific inhibition of platelet agglutination and aggregation by aromatic amidino compounds. THROMB HAEMOSTAS (In Press).Google Scholar

Copyright information

© Springer Science+Business Media New York 1978

Authors and Affiliations

  • K. M. Brinkhous
    • 1
  1. 1.Department of PathologyUniversity of North CarolinaChapel HillUSA

Personalised recommendations